Kentucky Retirement Systems Has $745,000 Position in Henry Schein, Inc. (NASDAQ:HSIC)

Kentucky Retirement Systems lowered its position in Henry Schein, Inc. (NASDAQ:HSIC) by 5.6% during the first quarter, according to its most recent Form 13F filing with the SEC. The fund owned 9,868 shares of the company’s stock after selling 580 shares during the period. Kentucky Retirement Systems’ holdings in Henry Schein were worth $745,000 at the end of the most recent reporting period.

Other hedge funds have also recently added to or reduced their stakes in the company. McGlone Suttner Wealth Management Inc. bought a new stake in Henry Schein during the fourth quarter worth approximately $39,000. Mather Group LLC. bought a new stake in Henry Schein during the first quarter worth approximately $97,000. Palisade Asset Management LLC bought a new stake in Henry Schein during the first quarter worth approximately $113,000. Covestor Ltd boosted its position in Henry Schein by 12.8% during the first quarter. Covestor Ltd now owns 1,511 shares of the company’s stock worth $114,000 after purchasing an additional 171 shares during the period. Finally, Benjamin F. Edwards & Company Inc. boosted its position in Henry Schein by 37.8% during the fourth quarter. Benjamin F. Edwards & Company Inc. now owns 1,516 shares of the company’s stock worth $114,000 after purchasing an additional 416 shares during the period. Institutional investors and hedge funds own 96.62% of the company’s stock.

Analysts Set New Price Targets

Several equities research analysts have recently weighed in on the company. Baird R W raised Henry Schein from a “hold” rating to a “strong-buy” rating in a research report on Monday, July 22nd. UBS Group reduced their price objective on Henry Schein from $82.00 to $80.00 and set a “neutral” rating for the company in a research report on Wednesday, May 8th. Piper Sandler reissued an “overweight” rating and issued a $86.00 price objective on shares of Henry Schein in a research report on Friday, June 21st. Evercore ISI reduced their price objective on Henry Schein from $75.00 to $72.00 and set an “in-line” rating for the company in a research report on Tuesday, July 9th. Finally, Barrington Research reissued an “outperform” rating and issued a $92.00 price objective on shares of Henry Schein in a research report on Friday, July 5th. One research analyst has rated the stock with a sell rating, six have issued a hold rating, six have given a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $81.67.

Henry Schein Price Performance

Henry Schein stock traded down $0.61 during mid-day trading on Monday, hitting $71.70. 464,448 shares of the company were exchanged, compared to its average volume of 1,101,791. The company has a quick ratio of 1.02, a current ratio of 1.75 and a debt-to-equity ratio of 0.47. The business has a fifty day moving average of $68.08 and a 200 day moving average of $71.83. Henry Schein, Inc. has a 1-year low of $60.01 and a 1-year high of $82.63. The company has a market capitalization of $9.18 billion, a PE ratio of 24.43, a price-to-earnings-growth ratio of 1.78 and a beta of 0.87.

Henry Schein (NASDAQ:HSIC) last released its quarterly earnings data on Tuesday, May 7th. The company reported $1.10 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.01 by $0.09. Henry Schein had a return on equity of 13.51% and a net margin of 3.12%. The firm had revenue of $3.17 billion during the quarter, compared to analyst estimates of $3.21 billion. During the same period in the prior year, the company posted $1.21 earnings per share. The business’s revenue for the quarter was up 3.7% compared to the same quarter last year. As a group, sell-side analysts expect that Henry Schein, Inc. will post 5.16 earnings per share for the current year.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.